Recognition of cellular implants by the brain's innate immune system

Immunology and Cell Biology

Volumn 89, Issue 4, 2011, Pages 511-516

  Bergwerf, Irene ^a   Tambuyzer, Bart ^a   De Vocht, Nathalie ^a   Reekmans, Kristien ^a   Praet, Jelle ^a   Daans, Jasmijn ^a   Chatterjee, Shyama ^b   Pauwels, Patrick ^b   Van Der Linden, Annemie ^a   Berneman, Zwi N ^a   Ponsaerts, Peter ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

astrocytes; bioluminescence imaging; cell transplantation; immune recognition; microglia; reporter genes

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN RECOGNITION; ASTROCYTE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOGENICITY; INNATE IMMUNITY; MICROGLIA; NONHUMAN; REVIEW; XENOGRAFT;

ANIMALS; BRAIN; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; IMMUNITY, INNATE; TISSUE THERAPY; TRANSPLANTATION IMMUNOLOGY;

RODENTIA;

EID: 79955754403     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.141     Document Type: Review

References (59)

1. Boucherie C, Hermans E. Adult stem cell therapies for neurological disorders: benefits beyond neuronal replacement? J Neurosci Res 2009; 87: 1509-1521.
2. Michel F, Lévesque TN, Rezak M. Therapeutic microinjection of autologous adult human neural stem cells and differentiated neurons for Parkinson's disease: five-year post-operative outcome. The Open Stem Cell Journal 2009; 1: 20-29.
3. Bachoud-Lévi AC, Gaura V, Brugières P, Lefaucheur JP, Boissé MF, Maison P et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 2006; 5: 303-309.
4. DedaH,InciMC,Kü rekçi AE, Sav A, Kayihan Ozgün E,Ustünsoy GE et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009; 11: 18-25.
5. Cristante AF, Barros-Filho TE, Tatsui N, Mendrone A, Caldas JG, Camargo A et al. Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients. Spinal Cord 2009; 47: 733-738.
6. Orlacchio A, Bernardi G, Orlacchio A, Martino S. Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. Curr Med Chem 2010; 17: 595-608.
7. Burns TC, Verfaillie CM, Low WC. Stem cells for ischemic brain injury: a critical review. J Comp Neurol 2009; 515: 125-144.
8. Deshpande DM, Kim YS, Martinez T, Carmen J, Dike S, Shats I et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 2006; 60: 32-44.
9. Chen B, Gao XQ, Yang CX, Tan SK, Sun ZL, Yan NH et al. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res 2009; 1284: 1-11.
10. Conte V, Royo NC, Shimizu S, Saatman KE, Watson DJ, Graham DI et al. Neurotrophic factors: pathophysiology and therapeutic applications in traumatic brain injury. Eur J Trauma 2003; 29: 335-355. (Pubitemid 38055542)
11. Törnqvist N, Björklund L, Almqvist P, Wahlberg L, Strömberg I. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease. Exp Neurol 2000; 164: 130-138. (Pubitemid 30490730)
12. Thoenen H, Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci 2002; 5(Suppl): 1046-1050. (Pubitemid 35247196)
13. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol 1977; 25: 1-54.
14. Arck PC, Gilhar A, Bienenstock J, Paus R. The alchemy of immune privilege explored from a neuroimmunological perspective. Curr Opin Pharmacol 2008; 8: 480-489.
15. Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunol Rev 2006; 213: 48-65. (Pubitemid 44401493)
16. Galea I, Bechmann I, Perry VH. What is immune privilege (not)? Trends Immunol 2007; 28: 12-18. (Pubitemid 44960159)
17. Tambuyzer BR, Ponsaerts P, Nouwen EJ. Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 2009; 85: 352-370.
18. Bailey SL, Carpentier PA, McMahon EJ, Begolka WS, Miller SD. Innate and adaptive immune responses of the central nervous system. Crit Rev Immunol 2006; 26: 149-188. (Pubitemid 43865180)
19. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010; 58: 253-263.
20. Wang XJ, Ye M, Zhang YH, Chen SD. CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease. J Neuroimmune Pharmacol 2007; 2: 259-264.
21. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007; 28: 138-145. (Pubitemid 46283692)
22. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 2008; 209: 294-301. (Pubitemid 351174127)
23. Pekny M, Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 2004; 204: 428-437. (Pubitemid 39468154)
24. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 2009; 29: 11511-11522.
25. Suzumura A, Takeuchi H, Zhang G, Kuno R, Mizuno T. Roles of glia-derived cytokines on neuronal degeneration and regeneration. Ann N Y Acad Sci 2006; 1088: 219-229. (Pubitemid 47092033)
26. Pizzi M, Sarnico I, Boroni F, Benarese M, Dreano M, Garotta G et al. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci 2004; 25: 301-311. (Pubitemid 38338641)
27. Thier M, März P, Otten U, Weis J, Rose-John S. Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons. J Neurosci Res 1999; 55: 411-422. (Pubitemid 29110549)
28. Sun N, Lee A, Wu JC. Long term non-invasive imaging of embryonic stem cells using reporter genes. Nat Protoc 2009; 4: 1192-1201.
29. Stripecke R, Carmen Villacres M, Skelton D, Satake N, Halene S, Kohn D. Immune response to green fluorescent protein: implications for gene therapy. Gene Ther 1999; 6: 1305-1312. (Pubitemid 29359025)
30. Ide C, Nakai Y, Nakano N, Seo TB, Yamada Y, Endo K et al. Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in the rat. Brain Res 2010; 1332: 32-47.
31. Inoue H, Ohsawa I, Murakami T, Kimura A, Hakamata Y, Sato Y et al. Development of new inbred transgenic strains of rats with LacZ or GFP. Biochem Biophys Res Commun 2005; 329: 288-295. (Pubitemid 40255452)
32. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 2005; 191: 344-360. (Pubitemid 40092879)
33. Bergwerf I, De Vocht N, Tambuyzer B, Verschueren J, Reekmans K, Daans J et al. Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice. BMC Biotechnol 2009; 9: 1.
34. Rosenzweig M, Connole M, Glickman R, Yue SP, Noren B, DeMaria M et al. Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood 2001; 97: 1951-1959. (Pubitemid 32239073)
35. Bian SY, Gai LY, Ye P, Yang YF, Wang H, Guo ZK et al. In vivo tracing of transplanted bone marrow mesenchymal stem cells with bioluminescence imaging. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009; 17: 1307-1311.
36. Tonti GA, Mannello F. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int J Dev Biol 2008; 52: 1023-1032.
37. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders-time for clinical translation? J Clin Invest 2010; 120: 29-40.
38. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009; 11: 377-391.
39. Chen X, Li Y, Wang L, Katakowski M, Zhang L, Chen J et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathol 2002; 22: 275-279. (Pubitemid 36142758)
40. Chu K, Kim M, Jeong SW, Kim SU, Yoon BW. Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 2003; 343: 129-133. (Pubitemid 36577532)
41. Sasaki M, Radtke C, Tan AM, Zhao P, Hamada H, Houkin K et al. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci 2009; 29: 14932-14941.
42. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005; 11: 96-104. (Pubitemid 40012003)
43. Lee H, Jin HK, Bae JS. Human umbilical cord blood-derived mesenchymal stem cells improve neurological abnormalities of niemann-pick type C mouse by modulation of neuroinflammatory condition. J Vet Med Sci 2010; 72: 709-717.
44. Cruzado JM, Bestard O, Grinyó JM. New immunosuppressive protocols with the advent of novel biological drugs. Transplantation 2009; 88: S20-S23.
45. Ronsyn MW, Daans J, Spaepen G, Chatterjee S, Vermeulen K, D'Haese P et al. Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnol 2007; 7: 90.
46. Swanger SA, Neuhuber B, Himes BT, Bakshi A, Fischer I. Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord. Cell Transplant 2005; 14: 775-786. (Pubitemid 43152982)
47. Rossignol J, Boyer C, Thinard R, Remy S, Dugast AS, Dubayle D et al. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med 2009; 13: 2547-2558.
48. Irons H, Lind JG, Wakade CG, Yu G, Hadman M, Carroll J et al. Intracerebral xenotransplantation of GFP mouse bone marrow stromal cells in intact and stroke rat brain: graft survival and immunologic response. Cell Transplant 2004; 13: 283-294. (Pubitemid 38620970)
49. Yasuhara T, Matsukawa N, Yu G, Xu L, Mays RW, Kovach J et al. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant 2006; 15: 231-238. (Pubitemid 43726182)
50. Xia G, Hong X, Chen X, Lan F, Zhang G, Liao L. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. J Perinat Med 2010; 38: 215-221.
51. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998; 95: 3908-3913. (Pubitemid 28173227)
52. Daadi MM, Li Z, Arac A, Grueter BA, Sofilos M, Malenka RC et al. Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther 2009; 17: 1282-1291.
53. Tambuyzer BR, Bergwerf I, De Vocht N, Reekmans K, Daans J, Jorens PG et al. Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol Cell Biol 2009; 87: 267-273.
54. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 2005; 106: 4057-4065. (Pubitemid 41775910)
55. Ishikane S, Ohnishi S, Yamahara K, Sada M, Harada K, Mishima K et al. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 2008; 26: 2625-2633.
56. Coyne TM, Marcus AJ, Woodbury D, Black IB. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 2006; 24: 2483-2492. (Pubitemid 44674309)
57. Coyne TM, Marcus AJ, Reynolds K, Black IB, Woodbury D. Disparate host response and donor survival after the transplantation of mesenchymal or neuroectodermal cells to the intact rodent brain. Transplantation 2007; 84: 1507-1516. (Pubitemid 350294727)
58. Rémy S, Canova C, Daguin-Nerrière V, Martin C, Melchior B, Neveu I et al. Different mechanisms mediate the rejection of porcine neurons and endothelial cells transplanted into the rat brain. Xenotransplantation 2001; 8: 136-148. (Pubitemid 32336223)
59. Bradbury MS, Panagiotakos G, Chan BK, Tomishima M, Zanzonico P, Vider J et al. Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. J Neurochem 2007; 102: 2029-2039. (Pubitemid 47329274)